Latest News - CRSToday

Wednesday, November 22, 2017 | FDA Approval/Clearance, Product Releases, RxSight

FDA Approves RxSight's Light Adjustable Lens, First IOL to Enable Refractive Correction After Cataract Surgery

RxSight announced that the FDA has approved the RxSight Light Adjustable Lens and the Light Delivery Device for patients with pre-existing astigmatism of ≥0.75 D undergoing cataract surgery. This a…

Read the full story

Wednesday, November 22, 2017 | Miscellaneous, Heidelberg Engineering

Heidelberg Engineering Announces the Passing of its Co-Founder Dr. Gerhard Zinser

Heidelberg Engineering announced the passing of one of its co-founders and managing director, Gerhard Zinser, on November 19, 2017. Dr. Zinser was a pioneer, an inventor, and the driving force behind …

Read the full story

Wednesday, November 22, 2017 | Product Releases

Salzburg Reading Desk Now Available in United States

SRD Vision announced that the Salzburg Reading Desk (SRD) is now available to clinicians and researchers in the United States as it is now considered 510(k) Class One exempt. “We are e…

Read the full story

Tuesday, November 21, 2017 | Clinical Trials

Nevakar Announces First Subject Dosed in its Phase 3 Clinical Trial of NVK-002 for the Treatment of Myopia in Children

Nevakar announced that the first subject has been dosed in a phase 3 clinical trial of NVK-002, the company's investigational, topical ophthalmic solution intended to slow the progression of myopi…

Read the full story

Tuesday, November 21, 2017 | Miscellaneous

European Medicines Agency to Relocate to Amsterdam, the Netherlands

The European Medicines Agency (EMA) will relocate to Amsterdam in the Netherlands. This decision was taken by the EU 27 Member States in the margins of the General Affairs Council (Art.50). The A…

Read the full story

Monday, November 20, 2017 | Partnerships

BioQ Pharma and Sophos Biotech Enter into Strategic Partnership for Postoperative Analgesia Therapy in Italy

BioQ Pharma and Sophos Biotech announced a strategic partnership agreement under which BioQ will supply, and Sophos will commercialize, a proprietary treatment for postoperative pain management in Ita…

Read the full story

Monday, November 20, 2017 | Medical Studies

Moorfields Eye Hospital Dubai's Model of Care Provides a Blueprint for International Healthcare Expansion in the Middle East

Moorfields Eye Hospital Dubai opened in 2007 and the Moorfields international operating model - developed over the last 10 years in the United Arab Emirates (UAE) - incorporates teaching and research …

Read the full story

Monday, November 20, 2017 | Earnings & Financials

Aston EyeTech Completes £5m Series A Equity Round

Aston EyeTech announced it has completed a £5m Series A funding round. The company will use this new funding to accelerate product development and support the 2018 launch of its new prod…

Read the full story

Monday, November 20, 2017 | Miscellaneous

Eye to the Sky: Ophthalmologists Aided Hurricane Response

Eye care is one of the most common acute medical needs after natural disasters. After recent hurricanes devastated Houston, Texas, and Puerto Rico, ophthalmologists were quick to respond, but having a…

Read the full story

Friday, November 17, 2017 | Medical Studies

Choose DMEK Over DSEK After Glaucoma Surgery

In patients requiring cornea transplant who have already had glaucoma surgery, Descemet membrane endothelial keratoplasty (DMEK) provides better outcomes than Descemet-stripping endothelial keratoplas…

Read the full story

Friday, November 17, 2017 | Clinical Trials, Glaucoma, Implandata Ophthalmic Products, IOP

Successful First-in-Human Testing of Implandata’s Next-Generation Eyemate Micro-Sensor for Improved Monitoring of Glaucoma Patients

Implandata Ophthalmic Products reported that its next-generation Eyemate micro-sensor implant for intraocular placement has successfully passed first-in-human validation.  “Thi…

Read the full story

Thursday, November 16, 2017 | Conferences

SECO 2018 Launches Customized Educational Content to Ensure Attendees Have Access to the Latest Clinical Advances and Technologies

SECO International, which stages February 28 to March 4, 2018, in Atlanta, recognizes that success comes down to good patient care. And good patient care comes down to keeping up with the latest scien…

Read the full story

Thursday, November 16, 2017 | Miscellaneous, Bausch+Lomb

Bausch + Lomb Reports Over 1 Million Units of Contact Lens Materials Recycled on First Anniversary of One By One Recycling Program

Bausch + Lomb announced on "America Recycles Day" that its exclusive ONE by ONE recycling program has recycled a combined total of more than one million used contact lenses, blister packs, a…

Read the full story

Wednesday, November 15, 2017 | Management/Leadership, Aerpio Therapeutics

Aerpio Pharmaceuticals Announces Appointment of Michael Rogers as Chief Financial Officer

Aerpio Pharmaceuticals announced that Michael Rogers has been appointed Chief Financial Officer effective as of November 15, 2017. Mr. Rogers has more than 25 years of experience in the biopharmaceuti…

Read the full story

Wednesday, November 15, 2017 | Medical Studies

Report: Global Ophthalmic Drugs Market Expected to Reach $42,663 Million by 2023

The global ophthalmic drugs market was valued at $29,613 million in 2016, and is projected to reach $42,663 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. The retinal disorders segment …

Read the full story
Load More